News Medical on MSN22h
World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Open Access Government14h
MHRA approves trofolastat for prostate cancer imaging
The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...